Eupraxia Pharmaceuticals (EPRX) News
NASDAQ: EPRXHealth CarePharmaceuticals and BiotechnologyUSD
7.46-0.11 (-1.45%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
EPRX news summary
We found 1 recent headline mentioning Eupraxia Pharmaceuticals (EPRX): 1 in the past week and 1 in the past 30 days, most often from GlobeNewswire. For price context, EPRX is down 1.45% at $7.46. The most recent story, "Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences", was published by GlobeNewswire on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology